
Hyperglycemia is a common challenge during cancer treatment and palliation. In addition, many patients with pre-existing type 1 or type 2 diabetes undergoing cancer treatment develop iatrogenic hyperglycemia with unique features.

Your AI-Trained Oncology Knowledge Connection!


Published: June 15th 2016 | Updated: